Author:
Ashe Karen M.,Bangari Dinesh,Li Lingyun,Cabrera-Salazar Mario A.,Bercury Scott D.,Nietupski Jennifer B.,Cooper Christopher G. F.,Aerts Johannes M. F. G.,Lee Edward R.,Copeland Diane P.,Cheng Seng H.,Scheule Ronald K.,Marshall John
Publisher
Public Library of Science (PLoS)
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. First-in-human single-dose study of nizubaglustat, a dual inhibitor of ceramide glucosyltransferase and non-lysosomal glucosylceramidase: Safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending and multiple doses in healthy adults;Molecular Genetics and Metabolism;2024-01
2. Glucosylceramide depletion disrupts endolysosomal function in GBA-linked Parkinson’s fibroblasts?;2023-11-30
3. Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis;International Journal of Molecular Sciences;2023-09-27
4. Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial;The Lancet Neurology;2023-08
5. Therapies for lysosomal storage diseases: Principles, practice, and prospects for refinements based on evolving science;Molecular Genetics and Metabolism;2022-09